Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Osteoarticular sarcoidosis]

M Marvisi1

  • 1Divisione di Medicina Interna, Presidio Ospedaliero, Cortemaggiore, Piacenza.

Minerva Medica
|July 24, 1998
PubMed
Summary

Sarcoidosis commonly affects lymph nodes and lungs, with skeletal and joint involvement occurring in a significant percentage of patients. Early diagnosis and targeted therapies like methotrexate or hydroxychloroquine can manage sarcoidosis symptoms.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Edgar Morin, the complex thought and medicine.

Ethics, medicine, and public health·2022
Same author

Thyroid gland and pulmonary hypertension. What's the link?

Panminerva medica·2013
Same author

A new type of Hypersensitivity Pneumonitis: salami brusher's disease.

Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace·2012
Same author

DLCO correlates with intestinal inflammation in ulcerative colitis, but albuminuria does not.

Minerva gastroenterologica e dietologica·2007
Same author

Chronic obstructive pulmonary disease beyond cigarette smoke.

Respiration; international review of thoracic diseases·2005
Same author

Hyperthyroidism and pulmonary hypertension.

Respiratory medicine·2002

Area of Science:

  • Rheumatology
  • Pulmonology
  • Systemic autoimmune diseases

Context:

  • Sarcoidosis is a multisystem inflammatory disease.
  • Skeletal involvement occurs in 14% of patients, primarily as asymptomatic cystoid osteitis in hands and feet.
  • Joint involvement, particularly arthritis, affects 89% of patients with acute sarcoidosis, often presenting as migratory polyarthritis.

Purpose:

  • To review the manifestations, diagnosis, and treatment of sarcoidosis, with a focus on skeletal and joint involvement.
  • To highlight diagnostic tools such as MRI, gallium citrate 67 scintigraphy, and serum ACE evaluation.
  • To discuss therapeutic options including prednisone, methotrexate, chloroquine, and hydroxychloroquine.

Summary:

  • Skeletal sarcoidosis includes rare lytic lesions in vertebrae and long bones, often requiring open biopsy for diagnosis.
  • Acute sarcoidosis arthritis is typically polyarticular, migratory, and transient, frequently associated with erythema nodosum.
  • Chronic or erosive sarcoidosis is rare and linked to systemic disease, necessitating comprehensive evaluation.

Impact:

  • Provides a comprehensive overview of sarcoidosis, aiding clinicians in recognizing and managing diverse presentations.
  • Emphasizes the importance of appropriate diagnostic modalities for skeletal and joint sarcoidosis.
  • Offers insights into current and potential therapeutic strategies for managing sarcoidosis, improving patient outcomes.

Related Experiment Videos